NCT04921345 · Interventional trial
Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis
Overall registry status Completed
Phase 2
Conditions Moderate-to-Severe Atopic Dermatitis
Delaware Valley sites
- Galderma Investigational Site #8255 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory